Noninvasive measurement of oxygen saturation of the microvascular blood in Barrett's dysplasia by use of optical spectroscopy
To access this article, please choose from the options below
DISCLOSURE: The following author disclosed financial relationships relevant to this publication: H. J. C. M. Sterenborg: CEO of Luminostix, a start-up company that aims to commercialize DPS technology. This research is supported by the Dutch Technology Foundation STW, applied science division of NWO and the Technology Program of the Ministry of Economic Affairs, and by the National Institutes of Health, grant NIH/NCI U54 CA104677. All other authors disclosed no financial relationships relevant to this publication.
If you want to chat with an author of this article, you may contact him at a.amelink@erasmusmc.nl.
PII: S0016-5107(08)02499-1
doi:10.1016/j.gie.2008.08.039
© 2009 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
